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Abstract
Background: Although HIV continues to have a high prevalence among adults in sub-Saharan Africa (SSA), the
burden of noncommunicable diseases (NCD) such as diabetes and hypertension is increasing rapidly. There is an
urgent need to expand the capacity of healthcare systems in SSA to provide NCD services and scale up existing
chronic care management pathways. The aim of this study was to identify key components, outcomes, and best
practice in integrated service provision for the prevention, identification and treatment of HIV, hypertension and
diabetes.
Methods: An international, multi stakeholder e-Delphi consensus study was conducted over two successive rounds.
In Round 1, 24 participants were asked to score 27 statements, under the headings ‘Service Provision’ and ‘Benefits
of Integration’, by importance. In Round 2, the 16 participants who completed Round 1 were shown the
distribution of scores from other participants along with the score that they attributed to an outcome and were
asked to reflect on the score they gave, based on the scores of the other participants and then to rescore if they
wished to. Nine participants completed Round 2.
Results: Based on the Round 1 ranking, 19 of the 27 outcomes met the 70% threshold for consensus. Four
additional outcomes suggested by participants in Round 1 were added to Round 2, and upon review by
participants, 22 of the 31 outcomes met the consensus threshold. The five items participants scored from 7 to 9 in
both rounds as essential for effective integrated healthcare delivery of health services for chronic conditions were
improved data collection and surveillance of NCDs among people living with HIV to inform integrated NCD/HIV
programme management, strengthened drug procurement systems, availability of equipment and access to
relevant blood tests, health education for all chronic conditions, and enhanced continuity of care for patients with
multimorbidity.
Conclusions: This study highlights the outcomes which may form key components of future complex interventions
to define a model of integrated healthcare delivery for diabetes, hypertension and HIV in sub-Saharan Africa.
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Introduction
While HIV continues to have a high prevalence in sub-
Saharan Africa (SSA) among adults, the burden of non-
communicable diseases (NCD) is increasing rapidly, in
particular diabetes and hypertension [1]. Each year over
three-quarters (28 million) of global NCD deaths and
most premature deaths from NCDs (82%) occur in low-
to-middle-income-countries (LMICs). Cardiovascular
diseases account for most NCD deaths, 17.9 million
people annually, followed by cancers (9.3 million), re-
spiratory diseases (4.1 million), and diabetes (1.5 million)
[2]. The International Diabetes Federation reported that
the prevalence of diabetes in SSA is anticipated to
double between 2010 and 2030 [3]. It is estimated that
of approximately 650 million people in SSA, 10–20 mil-
lion may have hypertension [4]. However, these estima-
tions are based on scarce heterogenous studies and
many countries in SSA still lack detailed up-to-date
basic data on the prevalence of hypertension [5]. NCDs
are important contributors to the burden of disease in
countries at all stages of economic development. How-
ever, the Global Status Report on NCDs emphasizes that
the negative impacts of NCDs are particularly detrimen-
tal to populations with high poverty such as SSA [6], as
poverty exacerbates many health conditions [7].
In recent years, there have been rapid improvements
in HIV care programmes in SSA. Substantial global in-
vestment in health services has strengthened physical in-
frastructure, laboratory capacity, health information
systems, healthcare worker capacity development and
promoting delivery of antenatal care, family planning
and sexually transmitted infection (STI) management
[8]. This has led to the expansion of and improvements
in life-saving antiretroviral therapy (ART) which has
greatly decreased HIV related morbidity and mortality
[9]. Currently, about 65% of all people living with HIV
(PLHIV) in Africa regularly access care with antiretro-
viral therapy [10]. However, this has resulted in an age-
ing population of PLHIV, with the population becoming
more susceptible to NCDs, such as diabetes and hyper-
tension [11]. In contrast, health service provision for
NCDs in SSA remains poor and evidence on adherence
to treatment and retention in care is limited with only
5–20% of people with diabetes or hypertension thought
to be in regular care [12]. There is an urgent need to ex-
pand the capacity of healthcare systems in SSA to pro-
vide services for managing HIV and one or more NCDs
concurrently.
Within healthcare systems in SSA, as concern about
the management of NCDs among PLHIV grows, the
infrastructure and lessons learnt from the HIV
chronic disease management model are important re-
sources for those hoping to expand NCD prevention,
care, and treatment [13]. These include health
services which are stand-alone and vertically delivered
and have been combined with decentralisation and
task shifting, allowing primary health centres to treat
large numbers of patients with almost 70% of people
living with HIV-infection in regular care [14]. Given
the similarities between different chronic diseases
(their effects on health and individual functioning
share common pathways and outcomes), the health-
care systems, assessment tools to diagnose and man-
age patients, health professional capacity and
implementation strategies developed to provide con-
tinuity of care for HIV in SSA means they can poten-
tially be rapidly, efficiently, and effectively utilized to
support services for NCDs, particularly hypertension
and diabetes [13].
Potential benefits of HIV-NCD integration for the
health system and patients include a reduction in dupli-
cation and fragmentation of services, which would in-
crease efficiency of resource use and help patients
remain in care by reducing costs and inconvenience for
patients with multiple morbidities [15]. Furthermore,
screening for NCDs within HIV care programmes can
improve the identification of undiagnosed NCDs among
patients living with HIV and also contribute to improved
health outcomes [16]. Leveraging and adapting the exist-
ing HIV model to integrate with newly developing NCD
services is key to achieving integrated care systems that
are more convenient for patients. However, although a
number of models of integrated HIV/NCD care in SSA
have been established in recent years, the lack of
evidence-based care models for scaling up integrated
care makes it difficult for countries to develop effective
and contextually appropriate policy and practice based
strategies [17].
Given the importance of integrated care models to ad-
dress the issues outlined above, the aim of this study
was to determine consensus among experts on key com-
ponents/outcomes and best practices in integrated ser-
vice provision for the prevention, identification and
treatment of HIV, hypertension and diabetes.
Method
The study design utilised an international, multi-
stakeholder e-Delphi consensus study over two succes-
sive rounds. A web-based system designed to facilitate
the building and management of Delphi surveys (Delphi-
Man a g e r , h t t p : / /www . c ome t - i n i t i a t i v e . o r g /
delphimanager/), was used for data collection. The Del-
phi consensus technique is a survey method designed to
obtain the opinions of a group of experts on a topic,
with each round providing input to the next [18]. This
technique differs from other group decision making pro-
cesses in four ways: utilising anonymity, iteration and
controlled feedback, statistical group response and
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expert input [19]. The Delphi approach is an iterative
consensus technique that presents a series of sequential
questionnaires asking individuals to rank outcomes in
terms of priority for inclusion in a key components/out-
come set that should be used in interventions to opti-
mise the prevention, identification and treatment of
HIV, diabetes and hypertension in integrated services in
the SSA context.
This Delphi consensus study used two rounds with
participants being informed of the results of the prior
round and allowed to revise their opinion based on those
results. The goal was to achieve a pre-defined threshold
of consensus. Key to the Delphi approach is the ano-
nymity of participants. By ensuring that participants re-
main anonymous throughout the process, they are free
to revise their opinion without fear of reputational harm
or to refuse to revise their opinion without pressure
from the group to do so [20].
Data were collected from the selected group of global
expertson integrating diabetes, hypertension and HIV
Care in SSA by using formal consensus methods, defined
as “group facilitation techniques designed to explore the
level of consensus among a group of experts by synthe-
sising and clarifying expert opinions.” [21].
Selection of experts
Consistent with the purposive sampling approach used
by many Delphi studies [20], our sampling strategy fo-
cused on identifying potential experts on the topic of
interest and inviting them to participate in the study.
We identified potential experts through the ‘INTE-AF-
RICA’ consortium (n = 39) [22] and by contacting the
corresponding authors of manuscripts from a scoping
review we conducted on integrating care for diabetes,
hypertension and HIV in SSA (n = 38). Expressions of
interest to participate in the study were sought from the
77 identified experts.
Twenty-four participants returned an expression of
interest form and were sent an email invitation that in-
cluded information about the purpose and process of
the study and a link to the online version of the ques-
tionnaire in DelphiManager. The size of Delphi panels
can range widely and the 24 participants that agreed to
participate in this study is within the 10–50 typically rec-
ommended [23]. We asked the experts to commit their
participation for two planned Delphi rounds and in-
formed consent was obtained from all participants. Par-
ticipants were recruited between December 2019 and
January 2020. Consistent with the COMET method-
ology, we included researchers, policymakers, and aca-
demics in our sample of experts to ensure a broad
representation of opinions (Table 1). The establishment
of this panel was overseen by the INTE-AFRICA Work
Package 3 steering group which was responsible for
providing advice, ensuring delivery of Work Package 3
project outputs. The Delphi panel participants received
no financial incentive to participate in the study.
Round 1
Participants were asked to score the importance of 27
statements developed by the steering group [22] (see Ta-
bles 2 and 3) on a 9-point Likert scale. The statements
were grouped under two headings, (Service Provision
and Benefits of Integration) which were identified as be-
ing important to enhancing integration of diabetes and
hypertension management with HIV management in
SSA. For outcomes under the heading ‘Service Provision’
participants were asked to rate outcomes on a scale of
1–9 where 1 = lowest priority and 9 = highest priority.
For outcomes under the heading ‘Benefits of Integration’
participants were asked to rate outcomes on a scale of
1–9 where 1 = strongly disagree and 9 = strongly agree.
The Likert scale corresponds to the conventional format
used for comparative assessment and prioritisation of
different health options [24]. Participants could suggest
additional outcomes during Round 1 by adding their
suggested outcome(s) in a free text box. Due to time
constraints for completing the study, participants were
given a period of 1 week to complete round 1 of the sur-
vey and a reminder email was sent to those participants
who had not yet completed the survey 2 days prior to
the Round 1 deadline. Eighteen participants participated
in Round 1 (with two partial completions, therefore 16
participants completed). Suggested outcomes from
Round 1 were independently reviewed and coded by the
first and second author to determine their novelty (i.e.,
that they were not covered by existing outcomes in the
questionnaire). The first two authors could not reach
agreement on whether to include two of the suggested
outcomes, so clarification was sought from the last au-
thor (WC) and consensus was reached to include four of
the 10 suggested outcomes in Round 2..
Round 2
Round 2 included the 27 original outcomes, and four
additional outcomes suggested by respondents in Round
1. The 16 participants, who had completed Round 1,
were shown the distribution of Round 1 scores from
other participants along with the score that they attrib-
uted to an outcome. Participants were asked to reflect
on the score they had given to each statement, based on
the scores of the other participants. Using the same 9-
point Likert scale, they were invited to rescore if they
wanted to. Participants were given 1 week to complete
the second round of the survey. Through this process,
consensus was reached on key components/outcomes,
best practice, and likely benefits in integrated service
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provision for the prevention, identification and treat-
ment of HIV, hypertension, and diabetes in SSA.
Analysis
Data analysis was conducted using DelphiManager soft-
ware. The DelphiManager software provided the user
scores data for each statement. Consensus for each of
the statements was defined a priori as 70% or more of
the respondents scoring an outcome from seven to nine
and fewer than 15% scoring it one to three. Meeting the
consensus meant an outcome falling in both categories
of threshold ≥70 and < 15%, The cut-off points were se-
lected based on the most widely used cut of points in
Delphi studies [18, 23, 25]. This would illustrate an out-
come agreed as critically important by the majority and
as of little or no importance by a small minority. Al-
though there is no formal guidance for the reporting of
e-Delphi studies, we followed recommendations includ-
ing that patients and clinicians be involved; researchers
and facilitators avoid imposing their views on partici-
pants; and attrition of participants be minimised as out-
lined by Sinha et al. [26].
Ethical considerations
Ethical approval for the study was granted by the Hu-
man Research Ethics Committee at University College
Dublin (LS-19-91-Cullen) and all methods were per-
formed in accordance with the relevant guidelines and
regulations. Participants were made aware that taking
part in the study was optional and they could withdraw
their participation at any time without reason. All an-




Of the 24 participants who were invited to take part in
the study, 18 participated in Round 1 (6 of the invited
participants did not commence Round 175% response
rate). Participants’ ranking of outcome measures for
Round 1 is provided in Tables 2 and 3.
Based on Round 1 ranking, 19 of the 27 outcomes for
‘Service Provision’ & ‘Benefits of Integration’ combined
met the consensus threshold of ≥70% respondents scor-
ing an outcome from seven to nine and < 15% scoring it
Table 1 Demographic characteristics of invited participants who expressed an interest in participating
Participant (n=24) Location Category Completed Round 1 (n=16) Completed Round 2 (n=9)
1 UK Academic / researcher Yes No
2 UK Academic / researcher Yes No
3 Malawi Academic / researcher Yes Yes
4 Uganda Academic / researcher Yes No
5 Tanzania Policy maker Yes Yes
6 USA Academic / researcher Yes No
7 Tanzania Academic / researcher Yes No
8 UK Academic / researcher Yes Yes
9 Tanzania Academic / Physician Yes Yes
10 UK Academic / Physician / Policy maker Yes No
11 Tanzania Academic / Physician Yes Yes
12 UK Academic / researcher Yes Yes
13 Uganda Academic / researcher Yes Yes
14 Botswana Policy maker Yes No
15 UK Academic / Physician Yes Yes
16 Canada Researcher Yes Yes
17 Uganda Physician / Policy maker No No
18 UK Academic / researcher No No
19 Uganda Academic/ Physician No No
20 India Academic / researcher No No
21 Nigeria Academic / Physician aNo No
22 UK Researcher No No
23 Nigeria Academic / Researcher No No
24 USA Researcher aNo No
aParticipated in Round 1 but did not complete
McCombe et al. BMC Health Services Research         (2021) 21:1235 Page 4 of 9
one to three. (combined consensus rate =70.4%). With
regards to the ‘Service Provision’ items, 11 outcomes
met the consensus thresholds (consensus rate =73.4%),
whilst 4 outcomes (consensus rate = 26.7%) did not. Of
the 4 outcomes that did not meet thresholds, one item
(‘It is important that referral networks from primary to
secondary care are not adversely affected by integrated
care delivery in primary care’) did meet the <15%
threshold, but not the ≥70% requirement. Meanwhile,
for the 12 Round 1 ‘Benefits of Integration’ items, 8
items met the thresholds (consensus rate =6.7%), and
four did not (consensus rate = 33.4%) Of the items that
did not meet the thresholds, two (‘Patients are likely to
receive better quality of health education within the inte-
grated clinic as within current vertical care clinics’ and
‘Patients are likely to spend less time waiting in an inte-
grated clinic’) met the <15% threshold, but not the ≥
70% criteria. Those statements for which all respondents
scored 7–9 and statements for which most respondents
scored 1–3 are illustrated in Tables 2 and 3.
Round 2
Nine of Round 1’s 18 participants took part in and com-
pleted Round 2. Round 1’s participants suggested that
four outcomes be added in Round 2, thus resulting in a
new tally of 31 items for the combined measures. Two
outcomes were added to the ‘Service Provision’ measure
(‘Integrated clinics may need to be re-launched to avoid
being labelled as HIV clinics’ and ‘All health workers
should undergo training in the provision of integrated
Table 2 Likert Scale scores for ‘Service Provision’ statements in Rounds 1 and 2













Outcomes n n (%) n (%) n (%) n n (%) n (%) n (%)
Drug procurement systems for NCDs and HIV should be integrated 16 4 (25) 4 (25) 8 (50) 9 1 (11) 1 (11) 7 (78)
Drug procurement systems should be strengthened for NCDs for an integrated
care programme
16 0 (0) 0 (0) 16 (100) 9 0 (0) 0 (0) 9 (100)
Patients with a chronic disease should be offered a choice of whether to collect
routine medication from facilities or in the community
16 1 (6) 2 (12) 13 (82) 9 0 2 (22) 7 (78)
The same adherence interventions and adherence monitoring as used in HIV care
should be applied to all patients with a chronic disease
16 1 (6) 3 (18) 12 (76) 9 1 (11) 1 (11) 7 (78)
There should be availability of equipment and access to relevant blood tests for
routine monitoring for all conditions
16 0 (0) 0 (0) 16 (100) 9 0 (0) 0 (0) 9 (100)
Health education should be available for all chronic conditions within an
integrated care clinic
16 0 (0) 0 (0) 16 (100) 9 0 (0) 0 (0) 9 (100)
There should be community-based education programs utilizing existing social,
cultural and religious networks to proactively address stigma within NCD/HIV
care
16 0 (0) 3 (18) 13 (82) 9 0 (0) 0 (0) 9 (100)
Most patients with multi-morbidity should be managed by non-physician health
workers
16 6 (37) 4 (26) 6 (37) 9 5 (56) 1 (11) 3 (33)
There should be on-site training of health care workers on HIV and NCDs 16 0 3 (18) 13 (82) 9 0 (0) 0 (0) 9 (100)
An integrated care clinic should only deliver care to patients with multimorbidity 16 14 (88) 0 (0) 2 (12) 9 9 (100) 0 (0) 0 (0)
Task shifting should be an essential element of integrated care for HIV,
hypertension and diabetes
16 0 (0) 4 (26) 12 (74) 9 0 (0) 0 (0) 9 (100)
Comprehensive community based NCD/HIV services should be used to
propagate lifestyle modifications, adherence and follow up appointments so as
to reduce the burden of complications and co-morbidities
16 0 (0) 1 (6) 15 (94) 9 0 (0) 0 (0) 9 (100)
Improved data collection and surveillance of NCDs among PLHIV should be
used to inform integrated NCD/HIV programme management
16 0 (0) 0 (0) 16 (100) 9 0 (0) 0 (0) 9 (100)
It is important that referral networks from primary to secondary care are not
adversely affected by integrated care delivery in primary care
16 1 (6) 4 (26) 11 (68) 9 0 1 (11) 8 (89)
It is important that problems with drug ordering and delivery do not undermine
the capacity of ART sites to provide NCD care
16 0 1 (6) 15 (94) 9 0 (0) 0 (0) 9 (100)
aIntegrated clinics may need to be re-launched to avoid being labelled as HIV
clinics
16 NA NA NA 9 2 (22) 1 (11) 6 (67)
aAll health workers should undergo training in the provision of integrated
chronic care
16 NA NA NA 9 2 (22) 0 (0) 7 (78)
aAdditional outcome suggested by a respondent in Round 1 and added for Round 2
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chronic care’) and two were added to the ‘Benefits of In-
tegration’ measure (‘Acceptability of integration of dia-
betes and hypertension with HIV may not be acceptable
to all patients’ and ‘The success of integrated care de-
pends on how well the stakeholders work together’).
Twenty-two of the 31 outcomes (consensus rate =
71.0%) met the ≥ 70 and <15% criteria. For the 15 items
that were also on Round 1’s ‘Service Provision’ measure,
13 met the threshold criteria. Two items that did not
meet the criteria in Round 1 did so in Round 2. These
items were ‘Drug procurement systems for NCDs and
HIV should be integrated’ and ‘It is important that refer-
ral networks from primary to secondary care are not ad-
versely affected by integrated care delivery in primary
care’. Meanwhile, of the two items that were added to
Round 2, neither met the criteria. The second of these
items ‘All health workers should undergo training in the
provision of integrated chronic care’ did meet the ≥70%
mark, but not the <15% threshold. As for Round 2’s
‘Benefits of Integration’ measure, 7 items (consensus
rate = 58.4%) did meet the threshold criteria and 5 (con-
sensus rate = 41.7%) did not. One item that met the cri-
teria in Round 1 did not do so in Round 2. This item
was ‘Integrated care for diabetes, hypertension and HIV
can occur within the HIV care programme’. Of the two
items that were added to Round 2’s ‘Benefits of Integra-
tion’ measure, one met the threshold criteria. This was
the ‘ … success of integrated care depends on how well
the stakeholders work together’ measure.
Those statements for which all respondents scored 7–
9 and statements for which most respondents scored 1–
3 are illustrated in Tables 2 and 3. Those statements for
which all respondents scored 7–9 on both rounds are il-
lustrated in Tables 2 and 3.
Discussion
This study sought to identify key components/outcomes
and best practices in integrated service provision for the
prevention, identification and treatment of HIV, hyper-
tension, and diabetes. The results of our e-Delphi study
suggest that key experts largely agree on what key com-
ponents/outcomes and best practices should be involved
when addressing the high and increasing dual burden of
NCDs and HIV in sub-Saharan Africa.
The highest priority for service provisions was given
to the strengthening of drug procurement systems for
Table 3 Likert Scale scores for ‘Benefits of Integration’ statements in Rounds 1 and 2













Outcomes n n (%) n (%) n (%) n n (%) n (%) n (%)
Integrated services can enhance detection of HIV and its risk factors 16 3 (18) 5 (32) 8 (50) 9 2 (22) 3 (33) 4 (45)
Integrated services enhance detection of NCDs and their risk factors 16 2 (12) 2 (12) 12 (76) 9 1 (11) 1 (11) 7 (78)
Multi-morbidities (HIV, hypertension and/or diabetes) can be managed together
at the same time and place by the same health care team of clinicians and
nurses
16 0 (0) 2 (12) 14 (88) 9 0 (0) 1 (11) 8 (89)
Integrated services can be scaled-up within pre-existing structures 16 1 (6) 2 (12) 13 (82) 9 0 (0) 2 (22) 7 (78)
Integrated care will improve clinical outcomes for patients with multi-
morbidities of HIV, hypertension and/or diabetes
16 0 (0) 1 (6) 15 (94) 9 0 (0) 1 (11) 8 (89)
An integrated clinic will provide better continuity of care for patients with
multi-morbidities (HIV, diabetes and hypertension)
16 0 (0) 0 (0) 16 (100) 9 0 (0) 0 (0) 9 (100)
Integrated care for diabetes, hypertension and HIV can occur within the HIV
care programme
16 1 (6) 3 (18) 12 (76) 9 0 (0) 3 (33) 6 (66)
Integrated care for HIV diabetes and hypertension can be delivered in the
community
16 2 (12) 0 (0) 14 (88) 9 1 (11) 0 (0) 8 (89)
Integrated services may weaken the current HIV programme 16 9 (57) 4 (25) 3 (18) 9 8 (89) 0 (0) 1 (11)
Patients are likely to receive better quality of health education within the
integrated clinic as within current vertical care clinics
16 0 (0) 5 (32) 11 (68) 9 0 4 (45) 5 (55)
Patients are likely to spend less time waiting in an integrated clinic 16 1 (6) 7 (44) 8 (50) 9 0 (0) 5 (55) 4 (45)
Patients with a chronic disease are more likely to be retained in an integrated
care clinic
16 0 (0) 2 (22) 14 (78) 9 0 (0) 1 (11) 8 (89)
aAcceptability of integration of diabetes and hypertension with HIV may not be
acceptable to all patients
0 NA NA NA 9 3 (33) 1 (11) 5 (55)
aThe success of integrated care depends on how well the stakeholders work
together
0 NA NA NA 9 0 (0) 1 (11) 8 (89)
aAdditional outcome suggested by a respondent in Round 1 and added for Round 2
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NCDs within an integrated care programme and the
availability of equipment and access to relevant blood
tests for routine monitoring for all conditions. Health
education and community-based education pro-
grammes and services were also prioritised to address
the stigma within NCD/HIV care. There should be
onsite training of healthcare workers on HIV and
NCDs. Participants also believed improved data col-
lection and surveillance of NCDs among PLHIV
should be used to inform integrated NCD/HIV
programme management.
The results showed that participants strongly agreed
that an integrated clinic would provide better con-
tinuity of care and clinical outcomes for patients with
multi-morbidities. They believe patients with chronic
diseases are more likely to be retained in an inte-
grated care clinic and this care can be delivered in
the community. Additionally, participants strongly dis-
agreed that integrating these services may weaken the
current HIV programme. One item that met the cri-
teria in Round 1 did not do so in Round 2. This is a
common occurrence with the Delphi consensus tech-
nique as participants are shown the distribution of
Round 1 scores from other participants and asked to
reflect on their own Round 1 score and are invited to
rescore if they wanted to.
How this relates to other literature
Although this topic has been studied before [27–29], the
best practices in integrated care provision for the pre-
vention, identification and treatment of hypertension,
diabetes and HIV in SSA has yet to be identified. This
study provides a unique perspective by a group of ex-
perts on the topic in order to inform best practice in in-
tegrated care provision. The results of this study
reaffirm the view that an integrated clinic will provide
better continuity of care for patients with diabetes,
hypertension and HIV.
Barriers such as a lack of diagnostic equipment and
medication [17, 30], lack of trained staff or training [30,
31] lack of guidelines and operating protocols [32], and
perceived threat of integration to existing HIV success
[33] have all been cited as issues when implementing in-
tegrated HIV/NCD care in SSA. These barriers were also
highlighted by participants in this study as the need to
strengthen [34] drug procurement systems for NCDs,
improve the availability of equipment, and access to rele-
vant blood tests for routine monitoring for all conditions
were all strongly agreed upon. Health education and
community-based education programmes and services
were also prioritized.
The results of this study add to the existing literature
by highlighting the most important service provisions
and perceived benefits of integration, and particularly
useful for the African context where integrated care is
developing. This can be used as a guide to determining
key outcomes and interventions in future trials.
Limitations and strengths
This study employed the ‘Delphi’ consensus technique in
an attempt to identify key components/outcomes and
best practice in integrated service provision for the pre-
vention, identification and treatment of HIV, hyperten-
sion, and diabetes. The validity of study findings
depends on the composition of our e-Delphi panel. Rec-
ommended best practices in an e-Delphi study is to in-
volve a diverse set of panellists [23]. The presence of
diverse perspectives is likely to result in wider accept-
ance of the prioritized outcomes deemed important to
include in future trials. To minimise recruitment bias,
we invited a range of global and African stakeholder
groups (researchers, policymakers, and academics) to
participate in the study. While we could not control
which stakeholders would return an expression of inter-
est to participate in the study, the 24 expressions of
interest and the nine participants who completed both
rounds of the survey reflected a range of stakeholder
groups and countries and, thus, captured a broad range
of perspectives (see Table 1). The decision of 70% agree-
ment could be a limitation considering Round 1 was
only completed by 16 participants and Round 2 was only
completed by nine participants, as there is some uncer-
tainty as to what constitutes a consensus [26]. However,
a recent systematic review [35] noted that few Delphi
studies report response rates for all rounds and stated
that the median number of invited participants was only
17 in Delphi studies. Therefore, we believe that our sam-
ple size is sufficient. Additionally, as our sample was
chosen to be purposive, not representative, it can also be
concluded that the decrease in participants from Round
1 to Round 2 is acceptable.
Implications for research
Further research is needed to prioritise the outcomes
identified in this study into a core outcome set to iden-
tify the best measures required to evaluate the benefits,
challenges and cost-effectiveness of integration of HIV
and NCD services in SSA.
Conclusions
This study has identified the key components/outcomes
that are most important to a range of key stakeholders in
the field including researchers, policymakers, academics.
While our Delphi panel included experts based outside
SSA, we do not see this as being problematic as they were
all experts on integrating diabetes, hypertension and HIV
Care in SSA. The findings from this study will help guide
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future research when choosing key outcomes/interven-
tions for future trials in this area and the 22 items priori-
tised here that met the ≥ 70 and <15% criteria will be
useful to improve evidence synthesis in future systematic
reviews. The identified key components are further essen-
tial to the generation of a culturally appropriate and trans-
ferable model of integration for potential
operationalisation in Africa.
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